Grace Therapeutics (GRCE) Cost of Revenue (2020 - 2021)
Grace Therapeutics' Cost of Revenue was $40,000 in fiscal Q4 2021 (quarter ended Mar 31, 2021), up 11.1% from the prior quarter.
Powered by 
Analysis
Grace Therapeutics (GRCE) Cost of Revenue (2020 - 2021) Analysis & Trends
For FY2021 (ended Mar 31, 2021), Cost of Revenue at Grace Therapeutics came in at $76,000.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 3.27 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 8.10 Bn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 4.29 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | 4.40 Bn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 3.71 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 2.52 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 2.81 Bn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | 1.58 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 4.09 Bn |
| 10 | Grace Therapeutics | 31.41 Mn | -34.86 Mn | - | - |
API Access
Grace Therapeutics Cost of Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=GRCE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cost-of-revenue", "ticker": "GRCE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=GRCE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();